Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1990-6-21
|
| pubmed:abstractText |
This study shows that nimodipine significantly reduces levels of blood pressure in patients with mild and moderate essential hypertension. Hypotensive efficacy is less than with nifedipine, but side effects are light, and the drug is shown to reduce serum Na+ and cholesterol and there is regression of LVH (ECG).
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0950-9240
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
149-50
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading | |
| pubmed:year |
1990
|
| pubmed:articleTitle |
Effect of treatment with nimodipine in patients with mild and moderate essential hypertension.
|
| pubmed:affiliation |
Cardiovascular Institute, Chinese Academy of Medical Sciences, Beijing.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|